BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 530251)

  • 1. Choline: binding studies provide some evidence for a weak, direct agonist action in brain.
    Palacios JM; Kuhar MJ
    Mol Pharmacol; 1979 Nov; 16(3):1084-8. PubMed ID: 530251
    [No Abstract]   [Full Text] [Related]  

  • 2. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.
    Fisher A; Brandeis R; Karton I; Pittel Z; Gurwitz D; Haring R; Sapir M; Levy A; Heldman E
    J Pharmacol Exp Ther; 1991 Apr; 257(1):392-403. PubMed ID: 2019998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of RS 86, a centrally acting m-cholinoceptor agonist with M1 and M2 receptors in rat brain and rat heart, respectively.
    Schubert T; Brunner F; Müller WE
    Pharmacopsychiatry; 1988 Nov; 21(6):321-3. PubMed ID: 3244760
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacologic characterization and functional role of muscarinic autoreceptors in the rabbit striatum.
    James MK; Cubeddu LX
    J Pharmacol Exp Ther; 1987 Jan; 240(1):203-15. PubMed ID: 3806384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic cholinergic receptors on cultured thyroid cells. II. Carbachol-induced desensitization.
    Champion S; Mauchamp J
    Mol Pharmacol; 1982 Jan; 21(1):73-7. PubMed ID: 6290867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potency ratio for the inhibition of 3H-QNB and 3H-cis-methyldioxolane binding predicts agonist or antagonist activity on muscarinic receptors.
    Moret C; Pastrie I; Briley M
    Methods Find Exp Clin Pharmacol; 1988 Oct; 10(10):619-21. PubMed ID: 3236936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic receptors of rabbit irides.
    Akesson C; Swanson C; Patil PN
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Mar; 322(2):104-10. PubMed ID: 6866127
    [No Abstract]   [Full Text] [Related]  

  • 8. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors.
    Baker SP; Posner P
    Mol Pharmacol; 1986 Nov; 30(5):411-8. PubMed ID: 3773882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.
    Kenakin T; Boselli C
    J Pharmacol Exp Ther; 1989 Sep; 250(3):944-52. PubMed ID: 2778720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic acetylcholine receptor-mediated phosphoinositide turnover in cultured cerebellar granule cells: desensitization by receptor agonists.
    Xu J; Chuang DM
    J Pharmacol Exp Ther; 1987 Jul; 242(1):238-44. PubMed ID: 3039110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kindling: a pharmacological approach.
    Wasterlain CG; Morin AM; Jonec V
    Electroencephalogr Clin Neurophysiol Suppl; 1982; 36():264-73. PubMed ID: 6962022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic comparison of selected agonists for the M1 muscarinic receptor in transfected murine fibroblast cells (B82).
    Mei L; Lai J; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1991 Feb; 256(2):689-94. PubMed ID: 1704434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic cholinergic receptor sites in cerebral blood vessels.
    Estrada C; Krause DN
    J Pharmacol Exp Ther; 1982 Apr; 221(1):85-90. PubMed ID: 7062294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of benzoyltropine and tropacocaine on several cholinergic processes in the rat brain.
    Meyer EM; Potter LT; De Vane CL; Irwin I; MacKay SL; Miller R; Ruttenber AJ
    J Pharmacol Exp Ther; 1990 Aug; 254(2):584-90. PubMed ID: 1974643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of deanol, choline and its metabolites on binding of [3H]quinuclidinyl benzilate to rat brain membranes.
    Haubrich DR; Risley EA; Williams M
    Biochem Pharmacol; 1979 Dec; 28(24):3673-4. PubMed ID: 533566
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential effects of alkylating agents on the multiple muscarinic receptor subtypes linked to activation of phospholipase C by carbachol in rat brain cortical membranes.
    Sallés J; Wallace MA; Fain JN
    J Pharmacol Exp Ther; 1993 Feb; 264(2):521-9. PubMed ID: 8437104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
    Lee JH; el-Fakahany EE
    J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine.
    Yamada S; Isogai M; Okudaira H; Hayashi E
    J Pharmacol Exp Ther; 1983 Aug; 226(2):519-25. PubMed ID: 6875862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development-related changes in colon muscarinic receptors.
    Zhang L; Chang JH
    Proc West Pharmacol Soc; 1995; 38():107-10. PubMed ID: 7480000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.